The End of Medicine as We Know It

Post a Comment


Wealthy Retirement

View in browser


AI Trading Tool 20 Years in the Making...
Now Revealed LIVE!

Profit Summit - August 2

Discover how one secret technology would have found same-day potential gains as high as 513%... 1,085%... even 1,367%...

Be among the first to see this amazing breakthrough in action... and even see live trade setups.

We're LIVE Wednesday, August 2, at 2 p.m. ET - Click Here to Sign Up FREE

Editor's Note: In today's column, we're sharing an article by The Oxford Club's Senior Markets Expert Matt Benjamin from the July issue of The Oxford Communiqué.

In it, he explores what he believes will be the future of medicine in the U.S.

We think you'll enjoy it.

If you're interested in taking the guesswork out of your investments, check out Chief Investment Strategist Alexander Green's "Single-Stock Retirement Play."

He believes this stock has the makings of a "Perfect Stock" and could be the cornerstone of your retirement.

Find all of the imperative details here!

- Rachel Gearhart, Associate Publisher

The End of One-Size-Fits-All Medicine

Matt Benjamin, Senior Markets Expert, The Oxford Club

Matt Benjamin

Let's face it: Modern medicine relies on a considerable amount of educated guesswork.

I'm not criticizing healthcare professionals, medical researchers, or the makers of drugs and medical devices. They do admirable - and often heroic - work.

Advances in medicine have been reducing the death rate from cancer by several percentage points a year for decades. Deaths from cardiovascular disease have declined dramatically over the past century. And infectious diseases killed 19% fewer Americans in 2014 than they did in 1980.

Treatments for a wide variety of diseases and ailments continue to improve dramatically and rapidly. Oxford Club Chief Investment Strategist Alexander Green likes to point out that Moderna (Nasdaq: MRNA) and Pfizer (NYSE: PFE) had COVID-19 vaccines ready for clinical trials within a couple of months of the pandemic reaching the U.S. The fastest vaccine development prior to this, for mumps in 1967, took four years.

But we're all familiar with the experience of going to the doctor or the hospital and being told that a treatment that works for most people will probably work for us. And the process of determining the effectiveness of a treatment or drug for an individual often involves trial and error.

That's because there is significant genetic diversity both across and within population groups. Our genetic differences impact our vulnerability to various diseases and affect how well we respond to specific treatments.

We've long known that certain populations are more susceptible to particular diseases. For example, sickle cell anemia disproportionately affects people of African descent, and Tay-Sachs disease disproportionately affects people of Ashkenazi Jewish descent.

But genetic differences between one population group and the next are modest. The vast majority of human genetic diversity is at the individual level, not between ethnic, geographical and racial groups.

And that's been a major obstacle for modern medicine.


🚀 Outperform Stocks With the Commodities Boom! 🚀

Worried about the stock market? It's time to switch gears!

During the last commodities supercycle, commodities like gold rose by over 500% while the stock market returned nothing.

Join the Commodities Supercycle Summit with Marc Lichtenfeld to discover how to capitalize on the next supercycle.

Don't miss out - click here now 📈💫

Because of your individual genetic code, you might be at greater risk for certain diseases. And each of us can respond to a plethora of drugs and treatments in different ways.

Indeed, small variations in your genetic code mean that you might not react well to a generally effective treatment or drug, or that you might experience greater side effects.

Of course, this knowledge is not new. Doctors have always known that some individuals would not respond well to certain cures; they just couldn't determine who those individuals would be. Thus the guesswork that is often involved in medicine.

Today, however, there is something they can do about it: It's called personalized, or precision, medicine.

An Individual Approach

Essentially, this emerging field of medicine is about determining important genetic traits in an individual in order to tailor a treatment regime to that person.

"If doctors know your genes, they can predict drug response and incorporate this information into the medical decisions they make," said Dr. Rochelle Long, a pharmacogenomics expert at the National Institutes of Health.

And understanding a person's genetic makeup is becoming easier every day due to various technologies that can handle the enormous amounts of data involved...

Reveal Genetic Advancements
Investment U Conference 2024 at the Ojai Valley Inn & Spa in Ojai, California. Don't miss out!

"007" of Investing Reveals Top $1.1B+ Dealmaking Secrets. Click Here for No-Holds-Barred Presentation.

"I Guarantee You'll Have the Chance to Double Your Money - or More - on This Stock Over the Next Year." - Marc Lichtenfeld, Chief Income Strategist


Self-Made Multimillionaire Reveals
the Top Secret of the Ultra-Rich

Mega Yacht

For the first time ever, multimillionaire investor Karim Rahemtulla is exposing the most guarded secret of the ultra-rich.

He's revealing how America's top 0.1% collect huge, passive income... day after day after day.

It's how Warren Buffett made TENS OF BILLIONS for his Berkshire Hathaway fund.

Best of all... you don't have to be rich to benefit from this method too!


Related Posts

There is no other posts in this category.

Post a Comment

Subscribe Our Newsletter